In vivo cartilage tissue engineering

Area of Science:

• Orthopedics
• Regenerative Medicine
• Biomaterials

Background:

• Current cartilage repair requires chondrocyte expansion via cell culture, necessitating two surgeries and high costs.
• In vivo chondrocyte isolation and stimulation could enable single-session treatment and reduce expenses.

Purpose of the Study:

• To evaluate a novel in vivo cartilage repair technique (MIV) in sheep.
• To compare MIV with matrix-induced autologous chondrocyte implantation (MACI) and other methods for treating full-thickness cartilage defects.

Main Methods:

• Full-thickness cartilage defects were created in sheep knees.
• The MIV group received diced autologous cartilage in the defect, covered by a collagen membrane.
• Comparisons included MACI, collagenase/growth factor-treated membranes, and untreated defects over 15 weeks.

Main Results:

• Both MACI and MIV groups showed significantly better healing compared to other groups.
• The addition of collagenase or growth factors to the MIV collagen membrane did not enhance repair outcomes.
• Collagenase treatment did not negatively impact surrounding cartilage.

Conclusions:

• The MIV method achieves results comparable to established MACI for cartilage repair in sheep.
• Further research is warranted to determine the efficacy of this in vivo approach in human patients.